Variant report
Variant | nsv521549 |
---|---|
Chromosome Location | chr9:12675264-12677412 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10960751 | chr9:12675264-12675265 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs536867107 | chr9:12675283-12675284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10960752 | chr9:12675284-12675285 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs75630385 | chr9:12675342-12675343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs74874037 | chr9:12675363-12675364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183357257 | chr9:12675379-12675380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs932761 | chr9:12675380-12675381 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs932760 | chr9:12675421-12675422 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs368686747 | chr9:12675462-12675463 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539898268 | chr9:12675477-12675478 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10960753 | chr9:12675522-12675523 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs577473010 | chr9:12675525-12675526 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187489386 | chr9:12675563-12675564 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572361287 | chr9:12675582-12675583 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192737461 | chr9:12675630-12675631 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561590981 | chr9:12675647-12675648 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs143272903 | chr9:12675660-12675661 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs16929342 | chr9:12675661-12675662 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs368443549 | chr9:12675662-12675663 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540152659 | chr9:12675685-12675686 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538590785 | chr9:12675707-12675708 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114774041 | chr9:12675710-12675711 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549154029 | chr9:12675715-12675716 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183213098 | chr9:12675737-12675738 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs534907325 | chr9:12675761-12675762 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187878854 | chr9:12675807-12675808 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35740654 | chr9:12675872-12675873 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547500694 | chr9:12675890-12675891 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570808055 | chr9:12675904-12675905 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539413298 | chr9:12675935-12675936 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553676410 | chr9:12675957-12675958 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556637698 | chr9:12675959-12675960 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs118044715 | chr9:12675979-12675980 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79213754 | chr9:12676022-12676023 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555530988 | chr9:12676192-12676193 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192654799 | chr9:12676202-12676203 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541690278 | chr9:12676231-12676232 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs16929345 | chr9:12676236-12676237 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs577582317 | chr9:12676271-12676272 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543022816 | chr9:12676287-12676288 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs62538950 | chr9:12676306-12676307 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs528959830 | chr9:12676316-12676317 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549242056 | chr9:12676330-12676331 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs559585507 | chr9:12676339-12676340 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568726294 | chr9:12676362-12676363 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145537844 | chr9:12676399-12676400 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35434002 | chr9:12676411-12676412 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs16929346 | chr9:12676417-12676418 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs148766195 | chr9:12676423-12676424 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142418753 | chr9:12676443-12676444 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:12672600-12675400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:12674400-12676400 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr9:12675400-12675600 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr9:12675600-12677400 | Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr9:12676400-12681000 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr9:12677400-12677800 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |